Q5145 Medicaid reimbursement rate by state (2026)
Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg. Medicaid pays a median of $19.79 for Q5145 across 12 states, from $12.77 in Nevada to $128.07 in New Mexico.
- States publishing
- 12
- National median
- $19.79units vary by state
- Lowest
- $12.77Nevada
- Highest
- $128.07New Mexico
What does Medicaid pay for Q5145?
12 state Medicaid programs publish a fee-for-service rate for Q5145. The national median is $19.79 (units differ between states). New Mexico pays the most, $128.07, and Nevada the least, $12.77, a 10.0x spread.
Q5145 rate by state: highest, middle and lowest
One like-for-like fee-for-service rate per state, ranked. The workspace lists all 12 states with every variant, modifier and effective date.
Frequently asked questions
What does Medicaid pay for Q5145?
It depends on the state. Of the 12 states with a published fee-for-service rate, the median is $19.79. New Mexico pays the most ($128.07) and Nevada the least ($12.77).
Which state pays the highest Medicaid rate for Q5145?
New Mexico, at $128.07, effective 2025-01-01.
Do managed-care plans pay the same rate for Q5145?
Not necessarily. Each state's plan contracts decide whether plans must pay at least the fee-for-service rate, pay a state-set rate, or negotiate their own. The workspace shows the rule for each state, cited to the contract or statute.